Literature DB >> 6184997

Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture.

A Patz.   

Abstract

Retinal neovascularization is a serious complication of the retinopathy associated with diabetes, branch vein occlusion, sickle cell anemia, and retrolental fibroplasia. Retinal capillary nonperfusion, demonstrated on fluorescein angiography, precedes the development of neovascularization in each of these conditions. Our working hypothesis is that the nonperfused (ischemic or hypoxic) retina liberates a vasoproliferative or angiogenic substance. Although I have delineated the clinical and experimental observations relating to the hypothesis of an ischemic-mediated angiogenesis substance, other postulated mechanisms for the development of retinal neovascularization may be involved. Recent observations on the experimental model of retrolental fibroplasia have demonstrated the markedly abnormal persistence and apparent proliferation of the hyaloid vessels in mice following oxygen-induced retinal vascular closure.

Entities:  

Mesh:

Year:  1982        PMID: 6184997     DOI: 10.1016/0002-9394(82)90297-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  27 in total

1.  The a- and b-wave latencies as a prognostic indicator of neovascularisation in central retinal vein occlusion.

Authors:  M Moschos; D Brouzas; M Moschou; G Theodossiadis
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

2.  Neovascular response in ischaemic central retinal vein occlusion after panretinal photocoagulation.

Authors:  I E Murdoch; P H Rosen; J S Shilling
Journal:  Br J Ophthalmol       Date:  1991-08       Impact factor: 4.638

3.  Beta-N-acetyl-glucosaminidase: possible role in ocular neovascularization.

Authors:  K M Morgan; W E Bruner; G F Lata; S S Hayreh
Journal:  Int Ophthalmol       Date:  1986-05       Impact factor: 2.031

4.  Capillary endothelial-cell mitogenic activity in experimental branch vein occlusion.

Authors:  E de Juan; E Stefánsson; J S Dickson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

5.  Experimental studies on the angiogenic activity of the detached retina.

Authors:  M Prost
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

6.  A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.

Authors:  G W Blankenship
Journal:  Trans Am Ophthalmol Soc       Date:  1987

7.  Experimental studies on the pathogenesis of retinopathy of prematurity.

Authors:  M Prost
Journal:  Br J Ophthalmol       Date:  1988-05       Impact factor: 4.638

Review 8.  Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.

Authors:  Min K Song; Basil D Roufogalis; Tom H W Huang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

9.  Intraocular oxygen tension in eyes with proliferative diabetic retinopathy with and without vitreous.

Authors:  N Maeda; Y Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

10.  Ten years experience with choroidal angiography using indocyanine green dye: a new routine examination or an epilogue?

Authors:  P M Bischoff; R W Flower
Journal:  Doc Ophthalmol       Date:  1985-09-30       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.